Pharmacology
Allergy, Immunology, and ENT
Cardiology
Emergency Medicine
Endocrinology
Adolescent Medicine
Gastroenterology
Infectious Diseases
Neurology
OB/GYN
Practice Improvement
Gynecology
Respiratory
Dermatology
Mental, Behavioral and Development Health
Oncology
Rheumatology
Sexual Health
Pain

Improving vaccination rates in high-risk groups

Name: Improving vaccination rates in high-risk groups
Uploaded: 2022-04-29T12:44:47.085Z
Description: A look at a recently presented study on improving 23-valent pneumococcal polysaccharide vaccine uptake in groups that are at high risk.

April 29, 2022

Miranda Hester

Video

A look at a recently presented study on improving 23-valent pneumococcal polysaccharide vaccine uptake in groups that are at high risk.

Anthony W. Gannon, MD, a pediatric endocrinilogist at Nemours Children's in Wilmington, Delaware, sat down with Contemporary Pediatrics to discuss a poster presented at the 2022 Pediatric Academic Societies meeting that examined the impact of a quality improvement program on improving 23-valent pneumococcal polysaccharide vaccine uptake in 3 groups that are at high risk. He shared the ins and outs of the research, how other health systems could consider a similar project, and what the next steps are.

Related Content

FDA accepts BLA for meningococcal ABCWY vaccine, target action date set

April 16th 2024

Article

The 5-in-1 vaccine candidate has the potential to reduce shots and simplify the immunization process.

What's going on with polio, monkeypox, and COVID-19

August 19th 2022

Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

Evaluating rotavirus vaccine uptake among Italian children

April 9th 2024

Article

A study on Italian vaccination rates and factors influencing Rotavirus vaccine acceptance.

What Omicron could mean for the pandemic

January 7th 2022

Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.